Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A longitudinal study to investigate innate immune reprogramming following Herpes Zoster vaccinati... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'Phase I/II study of Mezigdomide and Elranatamab for relapsed/refractory multiple myeloma patients... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'Phase Ib/II Study of Tislelizumab in Combination with Bevacizumab and Capecitabine in Advanced So... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose S... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Multicenter, Open-Label, First-in-Human Study to Evaluate the Safety, Tolerability, Ph... Read More
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07838740) titled 'A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities' on Sept. 09. Brief Summa... Read More
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07838961) titled 'Brain Stimulation to Improvement After Cerebellar Damage' on Sept. 18. Brief Summary: The... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pl... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, double-blind, placebo-controlled Phase 2 study to investigate the effi... Read More